Clinical trials in developing countries

Swissmedic’s role in protecting vulnerable participants

Switzerland has a central role to play in the respect of ethical norms for drug trials conducted in developing and emerging countries. However, the ethical controls carried out by the drug regulatory agency, Swissmedic, are clearly inadequate, as confirmed by an investigation conducted by Public Eye in Switzerland. The Swiss legislation itself has major gaps.